Search

Author/Creator Min, Young Joo

1. Cross-cultural application of the Korean version of the EORTC QLQ-ELD14 questionnaire for elderly patients with cancer. Issue 4 (July 2017)

Authors:
Goo, Ae Jin; Shin, Dong Wook; Yang, Hyung Kook; Park, Jong-Hyock; Kim, So-Young; Shin, Joo Yeon; Kim, Young Ae; Kim, Changhoon; Hong, Nam-Soo; Min, Young Joo; Park, Keeho
Journal:
Journal of geriatric oncology
Issue:
Volume 8:Issue 4(2017)
Page Start:
271
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: A retrospective analysis in Korea. Issue 2 (February 2015)

Authors:
Baek, Jin Ho; Sun, Jong-Mu; Min, Young Joo; Cho, Eun Kyung; Cho, Byoung Chul; Kim, Joo-Hang; Ahn, Myung-Ju; Park, Keunchil
Journal:
Lung cancer
Issue:
Volume 87:Issue 2(2015:Feb.)
Page Start:
148
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: A retrospective analysis in Korea. Issue 2 (February 2015)

Authors:
Baek, Jin Ho; Sun, Jong-Mu; Min, Young Joo; Cho, Eun Kyung; Cho, Byoung Chul; Kim, Joo-Hang; Ahn, Myung-Ju; Park, Keunchil
Journal:
Lung cancer
Issue:
Volume 87:Issue 2(2015:Feb.)
Page Start:
148
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study. Issue 12 (December 2019)

Authors:
Ahn, Myung-Ju; Han, Ji-Youn; Lee, Ki Hyeong; Kim, Sang-We; Kim, Dong-Wan; Lee, Yun-Gyoo; Cho, Eun Kyung; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Jong-Seok; Min, Young Joo; Kim, Jin-Soo; Lee, Sung Sook; Kim, Hye Ryun; Hong, Min Hee; Ahn, Jin Seok; Sun, Jong-Mu; Kim, Heung Tae; Lee, Dae Ho; Kim, Sohee
Journal:
Lancet oncology
Issue:
Volume 20:Issue 12(2019)
Page Start:
1681
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma. Issue 20 (4th August 2020)

Authors:
Hong, Min Hee; Heo, Seong Gu; Lee, Yun‐Gyoo; Kim, Hyo Song; Park, Keon Uk; Kim, Hoon‐Gu; Ko, Yoon Ho; Chung, Ik‐Joo; Min, Young Joo; Kim, Min Kyoung; Kim, Kyu Ryung; Yoo, Jinseon; Kim, Tae‐Min; Kim, Hye Ryun; Cho, Byoung Chul
Journal:
Cancer
Issue:
Volume 126:Issue 20(2020)
Page Start:
4521
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2019)

Authors:
Nakagawa, Kazuhiko; Garon, Edward B; Seto, Takashi; Nishio, Makoto; Ponce Aix, Santiago; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Imamura, Fumio; Yoh, Kiyotaka; Shih, Jin-Yuan; Au, Kwok Hung; Moro-Sibilot, Denis; Enatsu, Sotaro; Zimmermann, Annamaria; Frimod...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 12(2019)
Page Start:
1655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial. (September 2019)

Authors:
Kim, Dong-Wan; Lee, Dae Ho; Han, Ji-Youn; Lee, Jongseok; Cho, Byoung Chul; Kang, Jin Hyoung; Lee, Ki Hyeong; Cho, Eun Kyung; Kim, Jin-Soo; Min, Young Joo; Cho, Jae Yong; An, Ho Jung; Kim, Hoon-Gu; Lee, Kyung Hee; Kim, Bong-Seog; Jang, In-Jin; Yoon, Seonghae; Han, OakPil; Noh, Young Su; Hong, Ka Y...
Journal:
Lung cancer
Issue:
Volume 135(2019)
Page Start:
66
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study. (9th December 2021)

Authors:
Kim, Jwa Hoon; Seo, Seyoung; Kim, Jee Hyun; Koh, Su‐Jin; Ahn, Yongchel; Jung, Kyung Hae; Ahn, Jin‐Hee; Kim, Sung‐Bae; Kim, Tae Won; Hong, Yong Sang; Kim, Sun Young; Kim, Jeong Eun; Kim, Sang‐We; Lee, Dae Ho; Lee, Jae Cheol; Choi, Chang‐Min; Yoon, Shinkyo; Jeong, Jae Ho; Kim, Hwa Jung; Suh, Koung Jin
Journal:
Cancer medicine
Issue:
Volume 11:Number 3(2022)
Page Start:
705
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗